Pacira | PCRX - Trade Creditors


Pacira reported $17.69M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Assertio Holdings USD 14.66M 3.81M Sep/2025
Astellas Pharma JPY 181.95B 13.3B Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Cara Therapeutics USD 2.42M 2.42M Jun/2025
Coherus Biosciences USD 24.89M 12.73M Sep/2025
Heron Therapeutics USD 12.02M 20K Sep/2025
Ironwood Pharmaceuticals USD 1.61M 224K Sep/2025
J&J USD 11.99B 2.37B Dec/2025
Ligand Pharmaceuticals USD 27.76M 1.72M Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 17.69M 12.44M Sep/2025
Perrigo USD 469.7M 19.3M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
Teva Pharmaceutical Industries USD 2.53B 176M Dec/2025
Xeris Pharmaceuticals USD 6.53M 2.93M Sep/2025
Xoma USD 2.65M 1.52M Sep/2025
Zoetis USD 487M 77M Dec/2025